Caitlin Powell Gimpel

Providence Equity Partners' €2 billion sale of 50% stake in Globeducate to Wendel, 2024
Caitlin advised Providence Equity Partners, a specialist private equity investment firm focused on growth-oriented media, communications, education and technology companies throughout North America and Europe, in connection with its sale of a 50 percent stake in Globeducate, a primary and secondary education provider with a network of 65 international schools across 11 countries, to Wendel for an enterprise value of €2 billion. Providence will continue holding the remaining 50 percent in Globeducate.

Merck KGaA's US$600 million acquisition of Mirus Bio, 2024
Caitlin advised Merck KGaA, Darmstadt, Germany (MKDG), a leading science and technology company, in connection with the agreement to acquire life science company Mirus Bio for US$600 million.

Alstom €630 Million sale of its North American Signaling Business, 2024
Caitlin advised Alstom, a global leader in smart and sustainable mobility, in connection with its entry into a binding agreement to sell its North American conventional rail signaling business to Knorr-Bremse AG, the world's leading manufacturer of braking systems, for approximately €630 million.

La Marzocco and Eversys' US$1,4 billion business combination, 2023
Caitlin advised De' Longhi S.p.A., an Italian company listed on the Milan Stock Exchange, in connection with the business combination between La Marzocco International, a Seattle-based espresso and high-end coffee machine maker, and Eversys, a Swiss company active in the production and distribution of coffee machines. The transaction involves the creation of a new US-based corporate holding structure controlled by De' Longhi, resulting from the contribution by De' Longhi of Eversys and the acquisition by De' Longhi of a majority stake in La Marzocco International, from its affiliate De' Longhi Industrial and certain minority shareholders. The aggregate enterprise value of the transaction is equal to approximately US$1.4 billion.

BDT & MSD Partners' investment in I.M.A., 2023
Caitlin advised I.M.A. Industria Macchine Automatiche S.p.A. and its controlling shareholders in connection with an investment from BDT & MSD Partners. BDT & MSD Partners acquired its stake from international private equity fund BC Partners. The Vacchi family remains the majority owner of the IMA holding company.

Mediobanca's acquisition of Arma Partners, 2023
Caitlin advised Mediobanca – Banca di Credito Finanziario S.p.A. in connection with the acquisition of Arma Partners. Under the terms of the agreement, Mediobanca acquired Arma Partners to create a leading Digital Economy franchise within the CIB Division.

Merck's Acquisition of Erbi Biosystems, 2022
Caitlin advised Merck KGaA, a leading science and technology company, in connection with its acquisition of Erbi Biosystems, the developer of the Breez 2-ml microbioreactor technology platform.

AGIC Capital's acquisition of ATEC Pharmatechnik, 2022
Caitlin advised AGIC Capital, a growth-oriented private equity firm, in connection with the acquisition of a majority stake in German pharmaceutical company ATEC Pharmatechnik GmbH.

BC Partners and Bain Capital's €3.06 billion acquisition of Fedrigoni, 2022
Caitlin advised BC Partners LLP in connection with the €3.06 billion acquisition, together with Bain Capital, of Fedrigoni S.p.A., an Italy-based world leader in the production of value-added papers for luxury packaging and other creative solutions.

Valeas' sale, 2022
Caitlin advised the seller in connection with the sale of the entire share capital in Valeas S.p.A., a Milan based pharmaceutical company active in the Italian market.

Merck's acquisition of the MAST platform, 2022
Caitlin advised Merck KGaA, a leading science and technology company, in connection with the acquisition of the MAST platform (Modular Automated Sampling Technology) from Lonza.

Piovan's US$125 million acquisition of Sewickley Capital, 2021
Caitlin advised Piovan S.p.A., a global leader in the development and manufacturing of automation systems for the storage, conveying and processing of polymers, bio-resins, recycled plastic, food fluids, food and non-food powders, in connection with the acquisition of the entire share capital in Sewickley Capital, which owns 100 percent of IPEG, from the selling shareholders of Sewickley Capital for US$125 million.

Kedrion's acquisition of Prometic, 2021
Caitlin advised Kedrion S.p.A., an international pharmaceutical company engaged in developing and distributing plasma-derived medicinal products, in connection with its agreement to acquire Prometic Biotherapeutics Inc., a Canadian corporation and Prometic Bioproduction Inc., a US corporation and an option to acquire the remaining plasma-derived therapeutic business from NASDAQ listed company Liminal BioSciences Inc., together with approximately 100 employees.

De'Longhi Industrial's acquisition of an additional stake in La Marzocco, 2021
Caitlin advised De'Longhi Industrial S.A., the Luxembourg-based home appliances company, in connection with the acquisition of an additional 33.34 percent stake in La Marzocco International, a Seattle-based espresso and coffee machine maker, increasing its stake to over 50 percent.

IMA's acquisition of Thomas Engineering, 2021
Caitlin advised IMA S.p.A., world leader in the design and manufacturing of automatic machines for the processing and packaging of pharmaceuticals, cosmetics, food, tea and coffee, in connection with its acquisition of Thomas Engineering LLC, a USA leading player in the tablet-coating equipment industry.

International Game Technology's sale of Lottomatica to Gamenet, 2020
Caitlin advised International Game Technology Plc in connection with the agreement by its wholly owned subsidiary Lottomatica Holding S.r.l. to sell 100 percent of the share capital of Lottomatica Videolot Rete S.p.A. and Lottomatica Scommesse S.r.l. to Gamenet Group S.p.A., a subsidiary of funds managed by an affiliate of Apollo Global Management, Inc. for €950 million.

De'Longhi's US$420 million acquisition of Capital Brands Holdings, 2020
Caitlin advised De'Longhi Group in connection with the acquisition of 100 percent of Capital Brands Holdings, LLC for expected consideration of US$420 million.

BC Partners' €2.1 billion acquisition of SOFIMA, 2020
Caitlin advised BC Partners in connection with its almost €2.1 billion acquisition of an up to approximately 45 percent stake in SOFIMA, the holding company that controls IMA S.p.A.

Takeda's divestments, 2020
Caitlin advised Takeda Pharmaceutical Company Limited in connection with the divestments of select OTC and prescription pharmaceutical products in multiple transactions, including:

• the US$322 million divestment to Hasten Biopharmaceutic Co. Ltd. In China; and
• the US$670 million divestment to Orifarm in Europe.

Datalogic's sale of Solution Net Systems, 2020
Caitlin advised Datalogic USA, Inc., indirectly controlled by Datalogic S.p.A., an Italian company listed on the Italian Stock Exchange, in connection with the sale of 85 percent of its subsidiary Solution Net Systems Inc. to the US private equity fund Architect Equity.